Skip to main content
SupplementScience
Kava supplement
Botanical Extract

Kava: Benefits, Dosage, Forms & Research

Botanical Extract

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

Kava has the strongest clinical evidence of any herbal anxiolytic — a Cochrane review of 11 RCTs confirms significant anxiety reduction. Kavalactones modulate GABA-A receptors through multiple mechanisms. Take 120-250mg kavalactones daily from noble kava cultivars. Liver safety concerns are tied to poor-quality products, not properly prepared noble kava.

Key Facts

What it is
A root extract from Piper methysticum containing kavalactones that modulate GABA-A receptors and sodium channels
Primary benefits
  • Cochrane review of 11 RCTs confirms significant anxiolytic effect (Pittler 2003)
  • Multi-target mechanism: GABA-A, sodium channels, norepinephrine reuptake
  • Reduces GAD symptoms comparable to buspirone (Sarris 2013 RCT)
  • Rapid onset anxiolytic effects within 1-2 hours
  • Does not impair cognitive function at standard doses
Typical dosage
120-250mg kavalactones daily
Evidence level
Strong
Safety profile
Safe with Caution

What the Research Says

Kava has the strongest evidence base among herbal anxiolytics. The Cochrane review by Pittler & Ernst (2003) analyzed 11 RCTs totaling 645 participants and found kava significantly superior to placebo for anxiety (WMD 3.9 on Hamilton Anxiety Scale). Sarris et al. (2013) confirmed this in a well-designed 6-week RCT showing significant GAD symptom reduction with kavalactones. Regarding safety, the hepatotoxicity concern stems from case reports primarily linked to non-noble cultivars, use of stem and leaf material (not root), and ethanol/acetone extraction methods. Teschke et al. (2012) comprehensively reviewed the liver safety data and concluded that noble cultivar aqueous root extracts have an excellent safety profile, consistent with centuries of traditional Pacific Island use without liver toxicity.

Benefits of Kava

  • Anxiety reduction (Cochrane level evidence) — Pittler & Ernst (2003) systematically reviewed 11 RCTs in the Cochrane Database and concluded kava extract significantly reduced anxiety compared to placebo, with a weighted mean difference of 3.9 points on the Hamilton Anxiety Scale
  • Generalized anxiety disorder — Sarris et al. (2013) conducted a rigorous 6-week RCT of 75 patients with GAD, finding 120-240mg kavalactones daily (titrated based on response) significantly reduced anxiety compared to placebo, with a remission rate of 26% vs 6% for placebo
  • Multi-target anxiolytic mechanism — kavalactones modulate GABA-A receptors (kavain), block voltage-gated sodium channels (reducing neuronal excitability), inhibit norepinephrine reuptake, and modulate MAO-B activity, providing broad-spectrum anxiety relief through complementary pathways
  • Cognitive preservation — unlike benzodiazepines, kava does not impair cognitive function at therapeutic doses. Sarris et al. found no cognitive side effects, and some studies suggest mild cognitive enhancement alongside anxiety reduction
  • Muscle relaxation — kavalactones have direct skeletal muscle relaxant properties, providing physical relaxation that complements the psychological anxiolytic effects, beneficial for tension-type anxiety and stress-related muscle tension
Did you know?

Kava has the strongest evidence base among herbal anxiolytics.

Forms of Kava

FormBioavailabilityBest For
Standardized Kava Extract (30% kavalactones)Moderate-HighAnxiety — standardized dosing used in most clinical trials; ensure noble cultivar sourcing
WS 1490 (Standardized Extract)Moderate-HighClinically validated — the specific extract used in many European clinical trials including the Cochrane-reviewed studies
Traditional Kava Root Preparation (Water Extract)ModerateTraditional use — aqueous root preparation as consumed in Pacific Island cultures for thousands of years; safest preparation method
Noble Kava Root PowderLow-ModerateTraditional preparation — premium cultivar powder for preparing kava beverages; requires straining

Dosage Recommendations

General recommendation: 120-250mg kavalactones daily from standardized extract, or equivalent traditional preparation

Timing: For anxiety: divided doses 2-3 times daily. For sleep: single dose 1-2 hours before bed. Best taken on an empty stomach for faster absorption.

Dosage by Condition

ConditionRecommended DoseEvidence
Generalized anxiety120-240mg kavalactones daily (Sarris protocol: start 120mg, titrate to 240mg)Strong
Acute anxiety / situational stress100-200mg kavalactones as neededModerate
Sleep support150-250mg kavalactones, 1-2 hours before bedEmerging
Muscle tension120-200mg kavalactones dailyEmerging

Upper limit: 300mg kavalactones/day (German Commission E recommendation). Limit use to 3 months without medical supervision.

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

  • GI discomfort (most common side effect)
  • Headache (uncommon)
  • Dizziness (uncommon)
  • Drowsiness (dose-dependent)
  • Skin rash or "kava dermopathy" with chronic heavy use (reversible scaly skin)
  • Liver injury — rare but serious; linked primarily to non-noble cultivars, aerial plant parts, and acetone/ethanol extraction. Noble root water extracts have an excellent safety record in Pacific Island populations

Drug & Supplement Interactions

  • Hepatotoxic medications (acetaminophen, statins) — avoid combining due to theoretical additive liver stress
  • Alcohol — AVOID combining kava with alcohol (additive hepatotoxicity risk and CNS depression)
  • Benzodiazepines and sedatives — additive CNS depression, avoid combination
  • CYP1A2, CYP2C9, CYP2C19, CYP3A4 substrates — kavalactones inhibit multiple CYP enzymes
  • Levodopa / antiparkinson drugs — kava may reduce dopamine signaling, worsening Parkinson symptoms
  • MAO inhibitors — theoretical interaction due to kava's MAO-B effects
Check Kava interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

StressSleep Quality

Related Supplements

PassionflowerValerian RootL-Theanine

Frequently Asked Questions

Is kava safe for the liver?

The liver safety concern is important but nuanced. Rare cases of severe liver injury were reported primarily in Europe in the early 2000s, leading to temporary bans. Subsequent investigation (Teschke 2012) found most cases involved non-noble kava cultivars, aerial plant parts (not root), or improper extraction methods. Noble cultivar root, prepared traditionally with water, has been consumed safely by Pacific Island populations for over 3,000 years. To minimize risk: use only noble cultivar root extracts, avoid combining with alcohol, limit continuous use to 3 months, and avoid if you have existing liver disease.

How does kava compare to benzodiazepines for anxiety?

Kava has comparable efficacy to low-dose benzodiazepines for mild-to-moderate anxiety, but with critical advantages: no cognitive impairment, no physical dependence, no withdrawal syndrome, and no respiratory depression risk. The Cochrane review found significant anxiety reduction, and the Sarris (2013) RCT showed a 26% remission rate for GAD. Kava should not be considered equivalent to benzodiazepines for severe anxiety or panic disorder, but for mild-to-moderate generalized anxiety, it is a legitimate evidence-based alternative.

What are noble kava cultivars and why do they matter?

Noble kava cultivars are traditional varieties selected by Pacific Island cultures over centuries for their desirable psychoactive and safety profiles. They have a favorable kavalactone chemotype (high in kavain and dihydrokavain) and low levels of potentially hepatotoxic compounds like flavokavains. Non-noble or "tudei" (two-day) cultivars have different chemotypes and are associated with most adverse effect reports. When purchasing kava, look for products specifying noble cultivar sourcing — reputable brands will identify the cultivar (e.g., Borogu, Melo Melo, Pouni Ono).

References

  1. (). Kava extract for treating anxiety. Cochrane Database of Systematic Reviews. DOI
  2. (). Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. DOI
  3. (). Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine. DOI
  4. (). Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Australian and New Zealand Journal of Psychiatry. DOI